People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – David Okrongly has stepped down as CEO of Quanterix. Executive Chairman Martin Madaus is currently acting as the company's interim CEO. Madaus has been executive chairman since November 2010. Previously he was president and CEO of Millipore.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.